Home | About | Journals | Submit | Contact Us | Français |

**|**J R Soc Interface**|**v.6(34); 2009 May 6**|**PMC2659692

Formats

Article sections

Authors

Related links

J R Soc Interface. 2009 May 6; 6(34): 447–454.

Published online 2008 August 15. doi: 10.1098/rsif.2008.0258

PMCID: PMC2659692

Received 2008 June 16; Revised 2008 July 21; Accepted 2008 July 22.

Copyright © 2008 The Royal Society

This article has been cited by other articles in PMC.

Communication between cells is crucial for immune responses. An important means of communication during viral infections is the presentation of viral antigen on the surface of an infected cell. Recently, it has been shown that antigen can be shared between infected and uninfected cells through gap junctions, connexin-based channels, that allow the transport of small molecules. The uninfected cell receiving antigen can present it on its surface. Cells presenting viral antigen are detected and killed by cytotoxic T lymphocytes. The killing of uninfected cells can lead to increased immunopathology. However, the immune response might also profit from killing those uninfected bystander cells. One benefit might be the removal of future ‘virus factories’. Another benefit might be through the creation of ‘firebreaks’, areas void of target cells, which increase the diffusion time of free virions, making their clearance more likely. Here, we use theoretical models and simulations to explore how the mechanism of gap junction-mediated antigen transport (GMAT) affects the dynamics of the virus and immune response. We show that under the assumption of a well-mixed system, GMAT leads to increased immunopathology, which always outweighs the benefit of reduced virus production due to the removal of future virus factories. By contrast, a spatially explicit model leads to quite different results. Here we find that the firebreak mechanism reduces both viral load and immunopathology. Our study thus shows the potential benefits of GMAT and illustrates how spatial effects may be crucial for the quantitative understanding of infection dynamics and immune responses.

To successfully fight off pathogens, the host immune response needs to rapidly sense the presence of an intruder. This is possible only with communication between cells. During viral infections, one important message that needs to be communicated is the presence of the virus inside a cell. One way cells can signal the presence of virus is through the display of viral antigen on MHC I. Recently, another mode of communication has been demonstrated, namely the transport of antigen from one cell to another through gap junctions (Neijssen *et al*. 2005).

Gap junctions are small channels that can form between two cells to allow the transfer of small molecules (Harris 2001; Evans *et al*. 2006). The building blocks used to form gap junctions are connexins, which are expressed by many different cell types (Saez *et al*. 2003). While a number of studies have provided evidence that gap junctions play an important part during immune responses (Hu & Cotgreave 1997; Krenacs & Rosendaal 1998; Alves *et al*. 2000; Saez *et al*. 2000; Oviedo-Orta *et al*. 2001; Eugenin *et al*. 2003; Oviedo-Orta & Evans 2004; Matsue *et al*. 2006; Zhao *et al*. 2006), a recent study by Neijssen *et al*. (2005) is the first to suggest a possible mechanism. In this study, it was shown that *in vitro*, antigen peptides can be transported through gap junctions and presented on MHC I of the receiving cell, with subsequent recognition of the peptide–MHC complex by cytotoxic T lymphocytes (CTL). It has been suggested that such gap junction-mediated antigen transport (GMAT) might be useful during *in vivo* viral infections (Griffiths 2005; Heath & Carbone 2005; Li & Herlyn 2005; Neijssen *et al*. 2005).

One way through which GMAT could be beneficial is through the transport of antigen from infected cells to professional antigen-presenting cells, such as dendritic cells (DC). Since DC need to present viral antigen to activate T cells, but are not always infected by the virus, they need to acquire antigen by different mechanisms, a process termed cross-presentation (Cresswell *et al*. 2005; Trombetta & Mellman 2005). Several pathways for cross-presentation are known (Heath *et al*. 2004; Yewdell & Haeryfar 2005); GMAT might be another such pathway (Neijssen *et al*. 2005; Handel *et al*. 2007*a*).

Another way in which GMAT might help the immune response is by sharing antigen between infected and uninfected target cells. This can lead to cells that display antigen on MHC I without being infected. These uninfected but antigen-presenting bystander cells can be recognized and killed by CTL (figure 1).

Schematic of GMAT between target cells. Uninfected cells become infected. The infected cells produce free virus, and they also transfer viral antigen via gap junctions to neighbouring uninfected cells, turning these into antigen-presenting, uninfected **...**

The killing of target cells before they have become infected could lead to a reduction in viral load, due to the removal of potential ‘virus factories’. The reduced viral load may in turn reduce immunopathology. However, the bystander killing by CTL could outweigh the virus-induced cell death, thereby increasing immunopathology. Additionally, if one takes into account that CTL diverted to kill bystander cells are not available to kill infected cells, increased GMAT might be even less beneficial (Handel *et al*. 2007*a*).

The killing of bystander cells adjacent to infected cells has also been suggested to be beneficial through the creation of something similar to a firebreak (FB), an area void of target cells, that requires virions to diffuse further to encounter potential targets and so making their clearance more likely (Griffiths 2005; Heath & Carbone 2005; Li & Herlyn 2005; Neijssen *et al*. 2005). We suggested previously that the effect of such a FB mechanism would be most marked for densely packed target cells and slowly diffusing virions (Handel *et al*. 2007*a*). Here, we use two models, one based on ordinary differential equations (ODE) and the other based on a spatially explicit, agent-based model (ABM), to further explore the potential impact of GMAT during immune responses. We find that under the assumption of a well-mixed system with no FB mechanism in place, the bystander killing by CTL always outweighs the virus-induced cell death, thereby increasing immunopathology. Additionally, CTL that kill bystander cells are not available to kill infected cells, which can make the effect of GMAT worse. However, once spatial effects are taken into account, the results change. Our spatially explicit model demonstrates that the proposed FB mechanism can indeed lead to a reduction in both viral load and immunopathology, outweighing the negative effects of increased CTL killing of bystander cells.

We use two different models to study the impact of GMAT between infected and uninfected target cells. One model is based on ODE, and is implemented in Matlab R2007a (The Mathworks). The other model is a spatially explicit ABM, and is implemented in the freely available NetLogo platform, v. 4 (NetLogo 2008, http://ccl.northwestern.edu/netlogo/). All programs and scripts are available from the authors. The models are described in §2.1 and 2.2.

For the first model, we use a set of coupled ODEs to describe the dynamics of the infection process as schematically shown in figure 1. Uninfected cells, *U*, become infected by virus, *V*, according to a mass–action interaction at rate *b*. Infected cells produce virus at rate *p*, die at rate *d* and transport antigen to uninfected cells at rate *g*, turning these cells into bystander cells. Bystander cells can also become infected. Both infected and bystander cells present viral epitopes on MHC I and can therefore be recognized by the virus-specific CTL. CTL form complexes, *C*_{I} and *C*_{B}, with infected and bystander cells, respectively, at rate *k* and eventually kill these cells at rate *δ*. We assume that CTL always kill upon complex formation. Inclusion of a term that describes complex dissociation without killing was found not to alter the results. While in a complex with CTL but not yet killed, infected cells continue to produce virus. As long as CTL are bound in complexes, they are not able to engage new cells, thereby reducing the number of free CTL. The total number of CTL increases exponentially (clonal expansion) at rate *r*. We only model the CTL expansion phase, since the peak and subsequent decline of the CTL response usually occur several days after virus has been cleared. Free virus is cleared at a constant rate *c*. Since the rate of clearance is usually much faster when compared with the rate of virus absorption by target cells, we ignore the absorption term, as is customary for these models (Perelson & Nelson 1999; Perelson 2002). The equations for this model are given by

$$\frac{\text{d}U}{\text{d}t}=-bUV-gUI\phantom{\rule{1em}{0ex}}\phantom{\rule{1em}{0ex}}\text{uninfected}\phantom{\rule{0.25em}{0ex}}\text{cells},$$

$$\frac{\text{d}I}{\text{d}t}=bUV+bBV-dI-kXI\phantom{\rule{1em}{0ex}}\phantom{\rule{1em}{0ex}}\text{infected}\phantom{\rule{0.25em}{0ex}}\text{cells},$$

$$\frac{\text{d}B}{\text{d}t}=gUI-bBV-kXB\phantom{\rule{1em}{0ex}}\phantom{\rule{1em}{0ex}}\text{bystander}\phantom{\rule{0.25em}{0ex}}\text{cells},$$

$$\frac{\text{d}{C}_{\text{I}}}{\text{d}t}=kXI-\delta {C}_{\text{I}}\phantom{\rule{1em}{0ex}}\phantom{\rule{1em}{0ex}}\text{CTL}\u2013\text{infected}\phantom{\rule{0.25em}{0ex}}\text{cell}\phantom{\rule{0.25em}{0ex}}\text{complex},$$

$$\frac{\text{d}{C}_{\text{B}}}{\text{d}t}=kXB-\delta {C}_{\text{B}}\phantom{\rule{1em}{0ex}}\text{CTL}\u2013\text{bystander}\phantom{\rule{0.25em}{0ex}}\text{cell}\phantom{\rule{0.25em}{0ex}}\text{complex},$$

$$\frac{\text{d}V}{\text{d}t}=p(I+{C}_{\text{I}})-cV\phantom{\rule{1em}{0ex}}\phantom{\rule{1em}{0ex}}\text{free}\phantom{\rule{0.25em}{0ex}}\text{virus},$$

$$\frac{\text{d}T}{\text{d}t}=rT\phantom{\rule{1em}{0ex}}\phantom{\rule{1em}{0ex}}\text{total}\phantom{\rule{0.25em}{0ex}}\text{CTL},$$

$$X=T-{C}_{\text{I}}-{C}_{\text{B}}\phantom{\rule{1em}{0ex}}\phantom{\rule{1em}{0ex}}\text{free}\phantom{\rule{0.25em}{0ex}}\text{CTL}.$$

In appendix A, we prove that this model describes an acute, transient infection, for instance an influenza infection. The parameters for the model are given in table 1. We use values for the virus dynamics that are in line with the reported ones from influenza infections. To facilitate comparison with the spatial model, we consider a local region containing 10^{4} uninfected target cells.

The ABM is spatially explicit. We study a localized infection of a patch of epithelial tissue containing 10201 target cells on a grid of size 101×101. Initially, the target cell located at the central grid point starts out as infected and a CTL is randomly placed on the grid. The simulation runs in discrete time steps of 1 hour. In line with the values for the ODE model, an infected cell lives for 24 hours and produces eight virions per hour, for a total of approximately 200. Virions have a certain probability *p*_{v} of being cleared each hour. Since the ODE assumes a well-mixed system, the parameters describing mass–action rates for the ODE model have no direct equivalence in the spatially explicit model. For the ABM, we assume that both virions and CTL move randomly, with the virions diffusing at a slow speed, *m*_{v}, and the CTL at a higher speed, *m*_{t}, both given in units of grid points per hour. We further assume that a virion infects an uninfected or a bystander cell with a probability *p*_{i} upon landing on the same grid point. Equivalently, a CTL forms a complex with a bystander or an infected cell at probability *p*_{c}. Killing of infected or bystander cells by CTL after complex formation occurs with probability *p*_{k}. For *p*_{k}=1, killing is instantaneous; lower values of *p*_{k} correspond to delayed killing. CTL increase in number according to a discrete version of the exponential growth used for the ODE model. Gap junctions between infected and uninfected cells are formed at every time step with probability *G*_{p}, the gap-junction parameter for the ABM model.

During viral infection, pathology is often caused by both virus-induced cell death and immune-mediated damage, such as killing of infected cells by CTL (Krakauer & Nowak 1999; Wodarz & Krakauer 2000; Ganusov & Antia 2005). The mechanism of GMAT could reduce viral load due to the removal of uninfected bystander cells by CTL before these cells become infected, reducing the number of potential future virus factories (infected, virus-producing cells). This in turn leads to reduced virus-induced cell death. However, increased GMAT also leads to increased killing of uninfected bystander cells and therefore could cause increased immunopathology. To achieve an overall reduction of dead cells, the reduction in viral load due to removal of virus factories must result in a decrease in virus-induced cell death that is large enough to offset the bystander killing caused by CTL. Otherwise, GMAT does more harm than good. We use the ODE model to study the impact of GMAT in a well-mixed system, which might for instance apply to the spleen. First, we assume that the killing of bystander or infected cells by CTL is instantaneous (i.e. *δ*→∞). Using the ODE model described in §2, we show in figure 2 that increased GMAT can reduce the total viral load (the integrated viral load over the course of an infection). However, the killing of bystander cells increases immunopathology (the number of dead target cells).

Viral load and dead cells for different values of the gap-junction parameter, immediate killing by CTL. Shown are total viral load, integrated over the whole infection (solid lines) and number of dead cells at the end of the infection (dashed lines) as **...**

Next, we consider how taking into account the time it takes CTL to bind to and kill infected or bystander cells influences the results (Pilyugin & Antia 2000; Mempel *et al*. 2006). We set *δ*=48d^{−1}, which corresponds to an average of 30min to kill, in agreement with a recent experimental study (Mempel *et al*. 2006). For this scenario, an increase in bystander cells leads to more CTL being diverted from the task of removing infected cells. Figure 3 shows that this leads to an increase not only in immunopathology with increasing GMAT, but also in virus production.

Section 3.1 showed that GMAT is not beneficial in a well-mixed situation. However, it has been proposed that GMAT and removal of bystander cells could work like a FB: by killing target cells that surround an infected cell, virions exiting this infected cell will have to diffuse further before they encounter the next uninfected target cell. This leads to an increase in time spent outside a cell and makes the virions more susceptible to being cleared by the immune system (Griffiths 2005; Heath & Carbone 2005; Li & Herlyn 2005). We previously suggested that such a FB mechanism might be most relevant in situations where target cells are tightly packed and stationary. If the distances between target cells are small when compared with their size, removal of uninfected cells around an infected cell can significantly increase the distance a virion has to diffuse before it finds the next cell it can infect. Since the diffusion time scales with the square of the distance, the increase in diffusion time can be large (Handel *et al*. 2007*a*).

The FB idea is a fundamentally spatial mechanism; therefore, a spatial model is required to properly study it. We implemented such a model using NetLogo (2008, http://ccl.northwestern.edu/netlogo/), as described in §2. Using this model, we simulated infections for different levels of GMAT. Figure 4 shows a snapshot for a typical simulation. One can see that for a low GMAT rate, there is no empty space between infected (red) and uninfected (green) cells. By contrast, for a high GMAT rate, CTL (white) kill bystander cells (yellow) surrounding an infected cell. This leads to ‘empty’ space (i.e. an area filled with dead cells, void of uninfected target cells) between virions (blue) and target cells (see figure 4, orange ellipse). Virions have to diffuse further before they reach a target cell, making it more likely that those virions are cleared.

Snapshots of the infection simulation for (*a*) low and (*b*) high GMAT. Uninfected cells are green, infected cells red, bystander cells yellow, virus is blue and CTL are white. The black area represents tissue where epithelial cells have died. (New susceptible **...**

First, we investigated the impact of GMAT for different parameter combinations. For each simulation, we recorded the total number of dead cells and the total viral load, in analogy to the quantities plotted above for the ODE model. Figure 5 shows the average of those quantities as a function of the GMAT rate, scaled by the maximum value as in the earlier figures. As the figure shows, the FB mechanism works: increased GMAT rates lead to a reduction in viral load and dead cells. This result is rather robust to changes in parameters. Conditions on the parameters are that the virus is able to spread and cause an infection, and further that the infection is controlled before it reaches the edges of the grid, otherwise spurious boundary effects would occur. A large number of parameter combinations satisfy these conditions. We tried many of those combinations and always find that the viral load and the number of dead cells are reduced with increasing GMAT.

Normalized (*a*) total viral load and (*b*) number of dead cells obtained from the ABM for three different parameter combinations. Shown are averages of 200 simulations for different values of the gap-junction parameter. Parameters for scenario 1 (squares) **...**

Next, we investigated how virus diffusion speed, virus clearance rate and speed of bystander cell killing affect the impact of GMAT and the FB mechanism. To that end, we plot in figure 6 the normalized reduction in viral load and dead cells, divided by the number of FBs (bystander cells killed by CTL) for situations without GMAT and with high levels of GMAT. While significant variation between individual simulations exists, the trend as indicated by the mean values shows that increasing clearance rate or decreasing diffusion speed leads to a greater impact of GMAT. This is intuitively obvious since both fast clearance and slow diffusion increase the chances that during the time a virion traverses the empty space created by the killing of bystander cells, it is removed before it encounters the next target cell, thus increasing the impact of the FB. Figure 6 also shows that slower killing by CTL leads to a slightly higher impact of GMAT. This can be understood as follows: infected cells bound in complexes to CTL are able to produce virions until killing occurs. A delay in killing allows the complexed infected cells to produce more virions before CTL-induced death occurs. These virions diffuse to neighbouring uninfected cells and keep the infection alive. Therefore, the removal of neighbouring uninfected cells through GMAT becomes more important for the situation of delayed CTL killing.

The importance of gap junctions during immune responses seems to be clear (Oviedo-Orta & Evans 2004). Little is known about possible mechanisms although a number have been suggested (Griffiths 2005; Heath & Carbone 2005; Li & Herlyn 2005; Handel *et al*. 2007*a*). Here we used an *in silico* approach, based on mathematical models and simulations, to study the possible effects of one such recently discovered mechanism (Neijssen *et al*. 2005), GMAT.

Our results suggest that in a situation where the infection dynamics can be described by a well-mixed model—which could for instance apply to organs such as the spleen—GMAT is not a good strategy for the immune response. However, in a situation where target cells are tightly packed and stationary—which applies for instance to epithelial cells (Sousa *et al*. 2005), a target of many viruses—GMAT might lead to a phenomenon similar to a FB, which hinders virus spread and can therefore constitute a useful immune response strategy. For such a situation, we showed that faster virion diffusion speed and higher virion clearance rate increase the impact of the FB mechanism. One additional interesting feature our model uncovered was the finding that delayed killing of complexes can lead to a slight increase in the GMAT impact. This can be attributed to the fact that without GMAT, infected cells that are tagged for killing by CTL still have enough time to produce a limited number of virions before they die. It is important to point out that while this is an interesting finding, it depends on the details of the model. For instance, we did not include an eclipse phase in our model, the delay time between infection of cell and release of new virions. Depending on the exact length of this phase compared with the delay in killing, this small effect could vanish.

While we use parameter estimates that are in line with the experimental data, some values, such as the size of the different cells and virions, were chosen rather arbitrarily. As such, our study should be interpreted qualitatively. Details will differ between our models and reality. Nevertheless, we found the same qualitative results for a wide range of different parameter choices, suggesting that GMAT and the FB mechanism might be a robust feature that could play a role in viral infections. We therefore conclude that, if the biological system resembles a well-mixed situtation, GMAT would be a poor strategy. If, on the other hand, the system has the spatial structure of (for instance) a layer of epithelial cells, GMAT could be a good strategy. Of course, suggesting that GMAT could be beneficial for the immune response does not establish its occurrence *in vivo*. This will need to be checked with experimental studies. The contribution of our study is to provide theoretical, *in silico* evidence that GMAT could be beneficial and that it might well be worth looking for this mechanism *in vivo*. Overall, we find that taking into account spatial structure can lead to important differences in results. This agrees well with other recent studies showing that details of infection dynamics depend on the assumption of spatial structure (Beauchemin *et al*. 2005; Funk *et al*. 2005; Beauchemin 2006; Howat *et al*. 2006) and illustrates that the choice of modelling framework needs to be targeted to the problem at hand.

A.H., A.Y. and R.A. acknowledge support from the NIH. S.S.P. is partially supported by NSF grant DMS 0517954. A major part of this work was completed while S.S.P. was a visitor in the Biology Department at Emory University.

The main property of our ODE model is that for all initial conditions and parameter values (which are all non-negative, on biological grounds), the infection is always transient. In the long run, both the number of infected cells *I*(*t*) and the viral load *V*(*t*) vanish. Indeed, by adding appropriate equations, we find that

$$\dot{U}+\dot{I}+\dot{B}+{\dot{C}}_{\text{I}}+{\dot{C}}_{\text{B}}=-dI-\delta ({C}_{\text{I}}+{C}_{\text{B}})\le 0,$$

which implies that the non-negative sum

$$U(t)+I(t)+B(t)+{C}_{\text{I}}(t)+{C}_{\text{B}}(t)$$

is non-increasing in time, and hence bounded at all times. Moreover, we find that the sum of the integrals on the right-hand side is bounded above,

$$d{\int}_{0}^{t}I(s)\text{d}s+\delta {\int}_{0}^{t}({C}_{\text{I}}(s)+{C}_{\text{B}}(s))\text{d}s\le U(0)+I(0)+B(0)+{C}_{\text{I}}(0)+{C}_{\text{B}}(0),$$

for all times. Even in the absence of the immune response (*δ*=0), we have that

$${\int}_{0}^{t}I(s)\text{d}s\le \frac{1}{\delta}(U(0)+I(0)+B(0)+{C}_{\text{I}}(0)+{C}_{\text{B}}(0)).$$

Since *I*(*t*)≥0, the integral

$${\int}_{0}^{\infty}I(s)\text{d}s$$

converges, and in the limit we have ${\text{lim}}_{t\to \infty}I(t)={I}_{\infty}=0$. In other words, in the long run, the number of infected cells always vanishes.

The viral load *V*(*t*) has a similar behaviour. Indeed, we have that

$$V(t)-{V}_{0}=p{\int}_{0}^{t}(I(s)+{C}_{I}(s))\text{d}s-c{\int}_{0}^{t}V(s)\text{d}s,$$

or equivalently,

$$c{\int}_{0}^{t}V(s)\text{d}s=p{\int}_{0}^{t}(I(s)+{C}_{\text{I}}(s))\text{d}s+{V}_{0}-V(t)\le {V}_{0}+p{\int}_{0}^{\infty}(I(s)+{C}_{\text{I}}(s))\text{d}s.$$

Hence, the integral

$${\int}_{0}^{\infty}V(s)\text{d}s=\frac{1}{c}\left({V}_{0}+p{\int}_{0}^{\infty}(I(s)+{C}_{\text{I}}(s))\text{d}s\right)$$

also converges. This implies that ${\text{lim}}_{t\to \infty}V(t)={V}_{\infty}=0$, i.e. in the long run, the viral load also vanishes. All infections are therefore transient, with or without the immune response. Additionally, we have shown that the total viral load is always finite.

The second observation is that the infection always dies out before it entirely exhausts the available pool of uninfected cells. Again, this holds with or without the immune response. To show this, we observe that

$$\dot{U}=-bUV-gUI\le 0,$$

hence the uninfected pool is constantly declining (a rather trivial observation) and the limit ${U}_{\infty}={\text{lim}}_{t\to \infty}U(t)$ exists. Dividing out *U* and integrating, we find that

$$\text{ln}\phantom{\rule{0.25em}{0ex}}{U}_{\infty}-\text{ln}\phantom{\rule{0.25em}{0ex}}{U}_{0}=-b{\int}_{0}^{\infty}V(s)\text{d}s-g{\int}_{0}^{\infty}I(s)\text{d}s.$$

Substituting from above, we find that

$$\text{ln}\phantom{\rule{0.25em}{0ex}}{U}_{\infty}=\text{ln}\phantom{\rule{0.25em}{0ex}}{U}_{0}-\frac{b{V}_{0}}{c}-\left(\frac{b}{c}+g\right){\int}_{0}^{\infty}I(s)\text{d}s>-\infty .$$

Hence the residual pool of uninfected cells is always positive, i.e. *U*_{∞}>0.

This analysis shows that the model has the right properties needed to describe an acute, transient infection. Since analytical expressions for the total viral load and the total number of dead target cells are not available, we use numerical simulations of the system to determine those values.

- Alves L.A., Nihei O.K., Fonseca P.C., Campos-de- Carvalho A.C., Savino W. Gap junction modulation by extracellular signaling molecules: the thymus model. Braz. J. Med. Biol. Res. 2000;33:457–465. doi:10.1590/S0100-879X2000000400012 [PubMed]
- Baccam P., Beauchemin C., Macken C.A., Hayden F.G., Perelson A.S. Kinetics of influenza A virus infection in humans. J. Virol. 2006;80:7590–7599. doi:10.1128/JVI.01623-05 [PMC free article] [PubMed]
- Beauchemin C. Probing the effects of the well-mixed assumption on viral infection dynamics. J. Theor. Biol. 2006;242:464–477. doi:10.1016/j.jtbi.2006.03.014 [PubMed]
- Beauchemin C., Samuel J., Tuszynski J. A simple cellular automaton model for influenza A viral infections. J. Theor. Biol. 2005;232:223–234. doi:10.1016/j.jtbi.2004.08.001 [PubMed]
- Belz G.T., Xie W., Doherty P.C. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+T cell responses. J. Immunol. 2001;166:4627–4633. [PubMed]
- Brydon E.W.A., Smith H., Sweet C. Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release. J. Gen. Virol. 2003;84:2389–2400. doi:10.1099/vir.0.18913-0 [PubMed]
- Cairns H.J.F., Edney M., Destgroth S.F., Edney M. Quantitative aspects of influenza virus multiplication. 1. Production of incomplete virus. 2. Heterologous interference. 3. Average liberation time. 4. Definition of constants and general discussion. J. Immunol. 1952;69:155–181. [PubMed]
- Cresswell P., Ackerman A.L., Giodini A., Peaper D.R., Wearsch P.A. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 2005;207:145–157. doi:10.1111/j.0105-2896.2005.00316.x [PubMed]
- Eugenin E.A., Branes M.C., Berman J.W., Saez J.C. TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J. Immunol. 2003;170:1320–1328. [PubMed]
- Evans W.H., Vuyst E.D., Leybaert L. The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem. J. 2006;397:1–14. doi:10.1042/BJ20060175 [PubMed]
- Funk G.A., Jansen V.A.A., Bonhoeffer S., Killingback T. Spatial models of virus-immune dynamics. J. Theor. Biol. 2005;233:221–236. doi:10.1016/j.jtbi.2004.10.004 [PubMed]
- Ganusov V.V., Antia R. Pathology during acute infections: contributions of intracellular pathogens and the CTL response. Biol. Lett. 2005;1:239–242. doi:10.1098/rsbl.2004.0276 [PMC free article] [PubMed]
- Griffiths P.D. Mind the gap. Rev. Med. Virol. 2005;15:285–286. doi:10.1002/rmv.479 [PubMed]
- Handel A., Yates A., Pilyugin S.S., Antia R. Gap junction-mediated antigen transport in immune responses. Trends Immunol. 2007a;28:463–466. doi:10.1016/j.it.2007.08.006 [PubMed]
- Handel A., Longini I.M., Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comput. Biol. 2007b;3:e240. doi:10.1371/journal.pcbi.0030240 [PubMed]
- Harris A.L. Emerging issues of connexin channels: biophysics fills the gap. Q. Rev. Biophys. 2001;34:325–472. [PubMed]
- Heath W.R., et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 2004;199:9–26. doi:10.1111/j.0105-2896.2004.00142.x [PubMed]
- Heath W.R., Carbone F.R. Coupling and cross-presentation. Nature. 2005;434:27–28. doi:10.1038/434027a [PubMed]
- Howat T.J., Barreca C., O'Hare P., Gog J.R., Grenfell B.T. Modelling dynamics of the type I interferon response to
*in vitro*viral infection. J. R. Soc. Interface. 2006;3:699–709. doi:10.1098/rsif.2006.0136 [PMC free article] [PubMed] - Hu J., Cotgreave I.A. Differential regulation of gap junctions by proinflammatory mediators
*in vitro*. J. Clin. Invest. 1997;99:2312–2316. doi:10.1172/JCI119410 [PMC free article] [PubMed] - Krakauer D.C., Nowak M. T-cell induced pathogenesis in HIV: bystander effects and latent infection. Proc. R. Soc. B. 1999;266:1069–1075. doi:10.1098/rspb.1999.0745 [PMC free article] [PubMed]
- Krenacs T., Rosendaal M. Gap-junction communication pathways in germinal center reactions. Dev. Immunol. 1998;6:111–118. doi:10.1155/1998/45913 [PMC free article] [PubMed]
- Lee B.O., Rangel-Moreno J., Moyron-Quiroz J.E., Hartson L., Makris M., Sprague F., Lund F.E., Randall T.D. CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J. Immunol. 2005;175:5827–5838. [PubMed]
- Legge K.L., Braciale T.J. Lymph node dendritic cells control CD8+T cell responses through regulated FasL expression. Immunity. 2005;23:649–659. doi:10.1016/j.immuni.2005.11.006 [PubMed]
- Li G., Herlyn M. Information sharing and collateral damage. Trends Mol. Med. 2005;11:350–352. doi:10.1016/j.molmed.2005.06.009 [PubMed]
- Matsue H., Yao J., Matsue K., Nagasaka A., Sugiyama H., Aoki R., Kitamura M., Shimada S. Gap junction-mediated intercellular communication between dendritic cells (DCs) is required for effective activation of DCs. J. Immunol. 2006;176:181–190. [PubMed]
- Mempel T.R., Pittet M., Khazaie K., Weninger W., Weissleder R., von Boehmer H., von Andrian U. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity. 2006;25:129–141. doi:10.1016/j.immuni.2006.04.015 [PubMed]
- Neijssen J., Herberts C., Drijfhout J.W., Reits E., Janssen L., Neefjes J. Cross-presentation by intercellular peptide transfer through gap junctions. Nature. 2005;434:83–88. doi:10.1038/nature03290 [PubMed]
- Oviedo-Orta E., Evans W.H. Gap junctions and connexin-mediated communication in the immune system. Biochim. Biophys. Acta. 2004;1662:102–112. doi:10.1016/j.bbamem.2003.10.021 [PubMed]
- Oviedo-Orta E., Gasque P., Evans W.H. Immunoglobulin and cytokine expression in mixed lymphocyte cultures is reduced by disruption of gap junction intercellular communication. FASEB J. 2001;15:768–774. doi:10.1096/fj.00-0288com [PubMed]
- Perelson A. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2002;2:28–36. doi:10.1038/nri700 [PubMed]
- Perelson A.S., Nelson P.W. Mathematical analysis of HIV-1 dynamics
*in vivo*. SIAM Rev. 1999;41:3–44. doi:10.1137/S0036144598335107 - Pilyugin S., Antia R. Modeling immune responses with handling time. Bull. Math. Biol. 2000;62:869–890. doi:10.1006/bulm.2000.0181 [PubMed]
- Price G.E., Smith H., Sweet C. Differential induction of cytotoxicity and apoptosis by influenza virus strains of differing virulence. J. Gen. Virol. 1997;78(Pt 11):2821–2829. [PubMed]
- Regoes R.R., Barber D.L., Ahmed R., Antia R. Estimation of the rate of killing by cytotoxic T lymphocytes
*in vivo*. Proc. Natl Acad. Sci. USA. 2007;104:1599–1603. doi:10.1073/pnas.0508830104 [PubMed] - Saez J.C., Brañes M.C., Corvalán L.A., Eugenín E.A., González H., Martínez A.D., Palisson F. Gap junctions in cells of the immune system: structure, regulation and possible functional roles. Braz. J. Med. Biol. Res. 2000;33:447–455. doi:10.1590/S0100-879X2000000400011 [PubMed]
- Saez J.C., Berthoud V.M., Branes M.C., Martinez A.D., Beyer E.C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol. Rev. 2003;83:1359–1400. [PubMed]
- Sousa S., Lecuit M., Cossart P. Microbial strategies to target, cross or disrupt epithelia. Curr. Opin. Cell Biol. 2005;17:489–498. doi:10.1016/j.ceb.2005.08.013 [PubMed]
- Stray S.J., Air G.M. Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis. Virus Res. 2001;77:3–17. doi:10.1016/S0168-1702(01)00260-X [PubMed]
- Trombetta E.S., Mellman I. Cell biology of antigen processing
*in vitro*and*in vivo*. Annu. Rev. Immunol. 2005;23:975–1028. doi:10.1146/annurev.immunol.22.012703.104538 [PubMed] - Wodarz D., Krakauer D.C. Defining CTL-induced pathology: implications for HIV. Virology. 2000;274:94–104. doi:10.1006/viro.2000.0399 [PubMed]
- Yates A., Graw F., Barber D.L., Ahmed R., Regoes R.R., Antia R. Revisiting estimates of CTL killing rates
*in vivo*. PLoS ONE. 2007;2:e1301. doi:10.1371/journal.pone.0001301 [PMC free article] [PubMed] - Yewdell J.W., Haeryfar S.M.M. Understanding presentation of viral antigens to CD8+T cells
*in vivo*: the key to rational vaccine design. Annu. Rev. Immunol. 2005;23:651–682. doi:10.1146/annurev.immunol.23.021704.115702 [PubMed] - Zhao Y., Rivieccio M.A., Lutz S., Scemes E., Brosnan C.F. The TLR3 ligand polyI: C downregulates connexin 43 expression and function in astrocytes by a mechanism involving the NF-kappaB and PI3 kinase pathways. Glia. 2006;54:775–785. doi:10.1002/glia.20418 [PMC free article] [PubMed]

Articles from Journal of the Royal Society Interface are provided here courtesy of **The Royal Society**

PubMed Central Canada is a service of the Canadian Institutes of Health Research (CIHR) working in partnership with the National Research Council's national science library in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine(NCBI/NLM). It includes content provided to the PubMed Central International archive by participating publishers. |